Novel variants require established frameworks: emphasizing the role of ISTH diagnostic and classification guidelines

Mustafa Vakur Bor1,2

  • 1Unit for Thrombosis Research, Department of Regional Health Science, University of Southern Denmark, Esbjerg,, Denmark. vakur.bor@rsyd.dk.

Hereditas
|April 23, 2025
PubMed

Insights

This commentary emphasizes using International Society on Thrombosis and Haemostasis (ISTH) guidelines and bleeding assessment tools for diagnosing congenital fibrinogen disorders. Standardized methods improve the evaluation of these rare conditions.

Area of Science:

  • Hematology
  • Clinical Diagnostics
  • Rare Diseases

Background:

  • Congenital fibrinogen disorders are rare bleeding conditions.
  • Accurate diagnosis is crucial for patient management.
  • Current diagnostic approaches may lack standardization.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545